MSLI Share Price

Open 0.94 Change Price %
High 0.98 1 Day 0.00 0.00
Low 0.94 1 Week 0.00 0.00
Close 0.95 1 Month 0.08 9.20
Volume 2880 1 Year -0.49 -34.03
52 Week High 1.90
52 Week Low 0.00
MSLI Important Levels
Resistance 2 0.99
Resistance 1 0.97
Pivot 0.96
Support 1 0.93
Support 2 0.91
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SIRI 4.33 0.70%
SUSQ 14.20 -0.77%
AAPL 109.10 -0.73%
AAPL 109.10 -0.73%
More..
NASDAQ USA Top Gainers Stocks
QKLS 0.21 110.00%
LLEN 0.03 50.00%
LOCM 0.09 50.00%
RITT 0.09 50.00%
MEMP 0.64 33.33%
SKBI 0.19 26.67%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
CLNT 0.88 23.94%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
LIWA 0.01 -50.00%
AMCF 0.03 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
More..

Merus Labs International Inc. (NASDAQ: MSLI)

MSLI Technical Analysis 4
As on 5th Dec 2016 MSLI Share Price closed @ 0.95 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.24 & Sell for SHORT-TERM with Stoploss of 0.96 we also expect STOCK to react on Following IMPORTANT LEVELS.
MSLI Target for December
1st Target up-side 1.06
2nd Target up-side 1.13
3rd Target up-side 1.19
1st Target down-side 0.88
2nd Target down-side 0.81
3rd Target down-side 0.75
Merus Labs International Inc. ( NASDAQ USA Symbol : MSLI )
Sector : N/AIndustry:N/AFull Time Employees:N/ABusiness Summary Merus Labs International Inc., a specialty pharmaceutical company, is engaged in the acquisition and licensing of branded prescription medicines in the United States, Canada, and Europe. It offer And Other Stocks in Same Sector
MSLI
0.95 0.00 (0.00 %)
LT : Strong Sell
ST : Sell
MSLI Other Details
Segment EQ
Market Capital 45448548.00
Sector N/AIndustry:N/AFull Time Employees:N/ABusiness Summary Merus Labs International Inc., a specialty pharmaceutical company, is engaged in the acquisition and licensing of branded prescription medicines in the United States, Canada, and Europe. It offer
Industry N/AFull Time Employees:N/ABusiness Summary Merus Labs International Inc., a specialty pharmaceu
Offical website http://www.meruslabs.com
MSLI Address
MSLI
100 Wellington Street West
Suite 2110
Toronto, ON M5K 1H1
Canada
Phone: 416-593-3725
Fax: 416-593-4434
Interactive Technical Analysis Chart Merus Labs International Inc. ( MSLI NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Merus Labs International Inc.
MSLI Business Profile
Merus Labs International Inc. (Merus), formerly Envoy Capital Group Inc., is a specialty pharmaceutical company. The Company is engaged in the acquisition and licensing of branded prescription pharmaceutical products. It has products in the area of urology/women's health, anti-infective, and wound care. Its products include Factive, Emselex/Enable, Vancocin and Collacare and Collexa. On January 6, 2012, the Company acquired 51% of Orbis Pharma Inc. On March 7, 2012, the Company completed the acquisition of the North American product rights for FACTIVE (Gemifloxacin Mesylate) tablets from Cornerstone Therapeutics Inc. In August 2013, the Company announced that the divestiture of the North American product rights for FACTIVE (Gemifloxacin Mesylate) tablets to Okana Ventures Inc.